Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Prostate Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 31 articles: HTML format Text format

Single Articles

January 2020
1. HSU EC, Rice MA, Bermudez A, Marques FJG, et al
   Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.
   Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 1905384117.
   PubMed     Text format     Abstract available
   
   
   October 2019
2. MOPARTHI L, Pizzolato G, Koch S
   Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer.
   Proc Natl Acad Sci U S A. 2019 Oct 14. pii: 1906484116.
   PubMed     Text format     Abstract available
   
   
   July 2019
3. GUI B, Gui F, Takai T, Feng C, et al
   Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
   Proc Natl Acad Sci U S A. 2019 Jul 2. pii: 1908547116.
   PubMed     Text format     Abstract available
   
   
   June 2019
4. 
   Correction for Geng et al., Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.
   Proc Natl Acad Sci U S A. 2019 Jun 24. pii: 1908767116.
   PubMed     Text format    
   
   
   
5. 
   Correction for Lorenzo et al., Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth.
   Proc Natl Acad Sci U S A. 2019 Jun 10. pii: 1908514116.
   PubMed     Text format    
   
   
   May 2019
6. MA X, Huang J
   Predicting clinical outcome of therapy-resistant prostate cancer.
   Proc Natl Acad Sci U S A. 2019 May 21. pii: 1906812116.
   PubMed     Text format    
   
   
   
7. STOPSACK KH, Whittaker CA, Gerke TA, Loda M, et al
   Aneuploidy drives lethal progression in prostate cancer.
   Proc Natl Acad Sci U S A. 2019 May 13. pii: 1902645116.
   PubMed     Text format     Abstract available
   
   
   
8. ABIDA W, Cyrta J, Heller G, Prandi D, et al
   Genomic correlates of clinical outcome in advanced prostate cancer.
   Proc Natl Acad Sci U S A. 2019 May 6. pii: 1902651116.
   PubMed     Text format     Abstract available
   
   
   March 2019
9. ZHENG Y, Comaills V, Burr R, Boulay G, et al
   COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis.
   Proc Natl Acad Sci U S A. 2019;116:5223-5232.
   PubMed     Text format     Abstract available
   
   
   
10. PRADHAN AK, Bhoopathi P, Talukdar S, Scheunemann D, et al
    MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.
    Proc Natl Acad Sci U S A. 2019;116:5687-5692.
    PubMed     Text format     Abstract available
    
    
    January 2019
11. LORENZO G, Hughes TJR, Dominguez-Frojan P, Reali A, et al
    Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth.
    Proc Natl Acad Sci U S A. 2019 Jan 7. pii: 1815735116.
    PubMed     Text format     Abstract available
    
    
    December 2018
12. ZADRA G, Ribeiro CF, Chetta P, Ho Y, et al
    Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Dec 21. pii: 1808834116.
    PubMed     Text format     Abstract available
    
    
    November 2018
13. FONG LY, Jing R, Smalley KJ, Wang ZX, et al
    Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.
    Proc Natl Acad Sci U S A. 2018;115:E11091-E11100.
    PubMed     Text format     Abstract available
    
    
    October 2018
14. GARRIGUE P, Tang J, Ding L, Bouhlel A, et al
    Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors.
    Proc Natl Acad Sci U S A. 2018 Oct 22. pii: 1812938115.
    PubMed     Text format     Abstract available
    
    
    
15. ARORA H, Panara K, Kuchakulla M, Kulandavelu S, et al
    Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth.
    Proc Natl Acad Sci U S A. 2018 Oct 15. pii: 1812704115.
    PubMed     Text format     Abstract available
    
    
    
16. FENG S, Cheng X, Zhang L, Lu X, et al
    Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers.
    Proc Natl Acad Sci U S A. 2018;115:10094-10099.
    PubMed     Text format     Abstract available
    
    
    September 2018
17. 
    Correction for Chen et al., Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
    Proc Natl Acad Sci U S A. 2018;115:E9025.
    PubMed     Text format    
    
    
    August 2018
18. DUDANI JS, Ibrahim M, Kirkpatrick J, Warren AD, et al
    Classification of prostate cancer using a protease activity nanosensor library.
    Proc Natl Acad Sci U S A. 2018 Aug 20. pii: 1805337115.
    PubMed     Text format     Abstract available
    
    
    June 2018
19. NAVARRO HI, Goldstein AS
    HoxB13 mediates AR-V7 activity in prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1808196115.
    PubMed     Text format    
    
    
    May 2018
20. CHEN Z, Wu D, Thomas-Ahner JM, Lu C, et al
    Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
    Proc Natl Acad Sci U S A. 2018 May 29. pii: 1718811115.
    PubMed     Text format     Abstract available
    
    
    April 2018
21. FAN L, Zhang F, Xu S, Cui X, et al
    Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802415115.
    PubMed     Text format     Abstract available
    
    
    
22. TAKAYAMA KI, Suzuki T, Fujimura T, Takahashi S, et al
    COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1721957115.
    PubMed     Text format     Abstract available
    
    
    
23. LEE JK, Bangayan NJ, Chai T, Smith BA, et al
    Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1802354115.
    PubMed     Text format     Abstract available
    
    
    
24. ELLIS L, Loda M
    LSD1: A single target to combat lineage plasticity in lethal prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 16. pii: 1804205115.
    PubMed     Text format    
    
    
    
25. POWELL GRAY B, Kelly L, Ahrens DP, Barry AP, et al
    Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 16. pii: 1717705115.
    PubMed     Text format     Abstract available
    
    
    March 2018
26. SEHRAWAT A, Gao L, Wang Y, Bankhead A 3rd, et al
    LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
    Proc Natl Acad Sci U S A. 2018 Mar 26. pii: 1719168115.
    PubMed     Text format     Abstract available
    
    
    February 2018
27. HASHIMOTO K, Ochi H, Sunamura S, Kosaka N, et al
    Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
    Proc Natl Acad Sci U S A. 2018;115:2204-2209.
    PubMed     Text format     Abstract available
    
    
    October 2017
28. KUNDU M, Roy A, Pahan K
    Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-gamma.
    Proc Natl Acad Sci U S A. 2017;114:11482-11487.
    PubMed     Text format     Abstract available
    
    
    September 2017
29. TAKAYAMA KI, Suzuki T, Fujimura T, Yamada Y, et al
    Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.
    Proc Natl Acad Sci U S A. 2017 Sep 11. pii: 201706076.
    PubMed     Text format     Abstract available
    
    
    June 2017
30. FEI T, Chen Y, Xiao T, Li W, et al
    Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.
    Proc Natl Acad Sci U S A. 2017 Jun 13. pii: 201617467.
    PubMed     Text format     Abstract available
    
    
    May 2017
31. 
    Correction for Dash et al., Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.
    Proc Natl Acad Sci U S A. 2017 May 22. pii: 201706353.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: